|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 10 of 17 found articles
| Title: |
MuTAR study, Phase II, open-label study of erlotinib (E) treatment in patients (pts) with locally advanced or metastatic non-small cell lung cancer (mNSCLC) who present activating mutations (MUT+) in the tyrosine kinase (TKI) domain of the epidermal growth factor receptor (EGFR), assessed the efficacy of 1L in Portuguese pts with mNSCLC EGFR Mut+ |
| Author: |
Barata, F. Queiroga, H. Teixeira, E. Almodovar, M.T. Parente, B. Soares, M. |
| Appeared in: |
Revista portuguesa de pneumologia. English ed. |
| Paging: | Volume 22 (2016) nr. 5 pages 2 p. |
| Year: |
2016 |
| Contents: | |
| Publisher: |
Sociedade Portuguesa de Pneumologia |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 10 of 17 found articles
| << previous | next >> |